From: Secular reduction of excess mortality in hip fracture patients >85 years
Follow up time | Sex | Cohort | n | Dead, n (%) | Expected dead, n | SMR (95% CI) |
---|---|---|---|---|---|---|
0-6 months | Men | 78/79 | 417 | 105 (25.2) | 15.41 | 6.81 (4.47 – 8.35) |
88/89 | 546 | 137 (25.1) | 22.96 | 5.97 (4.90 – 7.13) | ||
96/97 | 279 | 72 (25.8) | 14.00 | 5.14 (3.90 – 6.61) | ||
Women | Â | Â | Â | Â | Â | |
78/79 | 1520 | 249 (16.4) | 48.74 | 5.11 (4.44 – 5.80) | ||
88/89 | 2073 | 371 (17.9) | 89.67 | 4.14 (3.68 – 4.61) | ||
96/97 | 975 | 156 (16.0) | 43.36 | 3.60 (2.99 – 4.26) | ||
6-12Â months | Men | Â | Â | Â | Â | Â |
78/79 | 312 | 21 (6.7) | 12.41 | 1.69 (1.02 – 2.48) | ||
88/89 | 409 | 38 (9.3) | 18.80 | 2.02 (1.38 – 2.70) | ||
96/97 | 207 | 19 (9.2) | 11.03 | 1.72 (1.00 – 2.59) | ||
Women | Â | Â | Â | Â | Â | |
78/79 | 1271 | 76 (6.0) | 41.45 | 1.83 (1.42 – 2.28) | ||
88/89 | 1702 | 148 (8.7) | 75.42 | 1.96 (1.65 – 2.30) | ||
96/97 | 819 | 70 (8.5) | 38.19 | 1.83 (1.42 – 2.29) | ||
1-5Â years | Men | Â | Â | Â | Â | Â |
78/79 | 291 | 129 (44.3) | 71.90 | 1.79 (1.47 - 2.18 ) | ||
88/89 | 371 | 208 (56.0) | 97.95 | 2.12 (1.82 – 2.47) | ||
96/97 | 188 | 95 (50.5) | 60.43 | 1.57 (1.26 – 1.96) | ||
Women | Â | Â | Â | Â | Â | |
78/79 | 1195 | 405 (33.9) | 285.68 | 1.42 (1.27 - 1.57) | ||
88/89 | 1554 | 701 (45.1) | 472.31 | 1.48 (1.37 - 1.61) | ||
96/97 | 749 | 342 (45.7) | 245.99 | 1.39 (1.24 - 1.55) | ||
5-10Â years | Men | Â | Â | Â | Â | Â |
78/79 | 162 | 83 (51.2) | 54.17 | 1.53 (1.14 – 2..04) | ||
88/89 | 163 | 88 (54.0) | 54.77 | 1.61 (1.25 – 2..06) | ||
96/97 | 93 | 58 (62.3) | 33.56 | 1.73 (1.32 – 2.26) | ||
Women | Â | Â | Â | Â | Â | |
78/79 | 790 | 366 (46.3) | 255.16 | 1.43 (1.28 – 1.60) | ||
88/89 | 853 | 455 (53.3) | 318.87 | 1.42 (1.29 – 1.58) | ||
96/97 | 407 | 258 (63.3) | 146.69 | 1.76 (1.54 – 2.02) |